Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
US Stock MarketDetailed Quotes
DBVT DBV Technologies
- 9.000
- -0.260-2.81%
Trading Apr 24 11:08 ET
246.51MMarket Cap-1.54P/E (TTM)
9.190High8.900Low42.23KVolume9.190Open9.260Pre Close382.61KTurnover0.33%Turnover RatioLossP/E (Static)27.39MShares9.58552wk High9.00P/B113.66MFloat Cap2.20552wk Low--Dividend TTM12.63MShs Float505.700Historical High--Div YieldTTM3.13%Amplitude2.200Historical Low9.059Avg Price1Lot Size
About DBV Technologies Company
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Chatillon, France.
Company Profile
SymbolDBVT
Company NameDBV Technologies
Listing DateOct 22, 2014
Issue Price21.64
Founded2002
CEOMr. Daniel Tasse
MarketNASDAQ
Employees110
Securities TypeDR
ADS Ratio1.0 : 5.0
Fiscal Year Ends12-31
Address107 avenue de la Republique
CityChatillon
ProvinceHF
CountryFrance
Zip Code92320
Phone33-1-55-42-78-78
Company Executives
- Name
- Position
- Salary
- Daniel Tasse
- Director and Chief Executive Officer
- 2.40M
- Dr. Pharis Mohideen, M.D.
- Chief Medical Officer
- 1.28M
- Virginie Boucinha
- Chief Financial Officer and Principal Accounting Officer
- 234.63K
- Michel De Rosen
- Non-Executive Chairman of the Board
- 10.81K
- Mailys Ferrere
- Independent Director
- --
- Julie O'Neill
- Independent Director
- 113.54K
- Daniele Guyot-Caparros
- Independent Director
- 118.94K
- Timothy E. Morris
- Independent Director
- 113.54K
- Michael J. Goller
- Independent Director
- 113.54K
- Daniel B. Soland
- Independent Director
- 113.54K
- Dr. Ravi Madduri Rao, M.D.
- Independent Director
- 113.54K
- Dr. Adora Ndu, Pharm.D.
- Independent Director
- 113.54K
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call